Which Biotech Winners Offer Continued Upside?

Michelle Ross discusses Abivax’s ulcerative colitis results and ScholarRock’s late-stage spinal muscular atrophy outlook.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!